The North America and Europe stroke diagnostics market size was valued at USD 2.18 billion in 2023 and is projected to grow at a CAGR of 7.2% from 2024 to 2030. The growing aging population, with an increased incidence of strokes among the elderly, is one of the key drivers for the marke... Read More »
October 2024The global cell-based assays market size was estimated at USD 17.26 billion in 2024 and is projected to grow at a CAGR of 8.8% from 2025 to 2030. The market is witnessing substantial growth driven by factors like the rising need for drug discovery, expanding research efforts in biotechno... Read More »
October 2024The global high-performance liquid chromatography market size was estimated at USD 4.96 billion in 2024 and is projected to grow at a CAGR of 6.0% from 2025 to 2030. The market's growth is anticipated as a result of advancements in high-performance liquid chromatography (HPLC) technology... Read More »
October 2024The global infectious disease molecular diagnostics market size was valued at USD 52.0 billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 3.9% from 2024 to 2030. The market surge is attributable to the ... Read More »
September 2024The Europe, Middle East, and Africa (EMEA) point-of-care (PoC) diagnostics market size was valued at USD 13.00 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2030. The growing geriatric population coupled with high incidence rates of... Read More »
September 2024The Asia Pacific In Vitro Diagnostics (IVD) market size was estimated at USD 18.0 billion in 2023 and is projected to expand at a CAGR of 6.2% from 2024 to 2030. The region’s aging population is increasing the demand for diagnostic tests as older individuals are more prone to chron... Read More »
September 2024The India malaria diagnostics market size was valued at USD 52.0 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 4.73% from 2024 to 2030. This growth is driven by the increasing public health burden of malaria across various regions of India. According... Read More »
September 2024The global lung cancer diagnostics market size was valued at USD 4.68 billion in 2023 and is projected to grow at a CAGR of 6.5% from 2024 to 2030. The market growth is high due to the rise in active smokers, unhealthy lifestyles, and pollution in urban areas. In addition, the demand for... Read More »
September 2024The global autoimmune disease diagnostics market size was valued at USD 5.39 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2030. Unceasing growth in new cases of autoimmune disease, increasing focus of professionals and practitioner... Read More »
September 2024The global disruptive behavior disorder treatment market size was valued at USD 1.42 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2030. This growth is attributed to increased awareness, enhanced diagnostic abilities, and a changing... Read More »
September 2024The Europe bladder cancer diagnostics market size was estimated at USD 786.10 million in 2023 and is expected to grow at a CAGR of 8.38% from 2024 to 2030. The market growth can be attributed to the ongoing advancements in noninvasive diagnostics and a shift toward a precision-based appr... Read More »
September 2024The global malaria diagnostics market size was estimated at USD 759.1 million in 2023 and is projected to grow at a CAGR of 2.6% % from 2024 to 2030. The market is being propelled by an increasing need for malaria diagnostics and the advent of innovative diagnostic methods. ... Read More »
September 2024The global liver disease diagnostics market size was valued at USD 35.37 billion in 2023 and is anticipated to grow at a CAGR of 6.61% from 2024 to 2030. A significant driver expected to boost the liver disease diagnostics market is the growing prevalence of both acute and chro... Read More »
September 2024The Asia Pacific point of care diagnostics market size was valued at USD 9.31 billion in 2023 and is projected to grow at a CAGR of 8.4% from 2024 to 2030. Asia Pacific witnessed significant growth in the point of care diagnostics market due to the rising healthcare expenditure, increase... Read More »
September 2024The global employer and workplace drug testing market size was estimated at USD 5.90 billion in 2023 and is projected to grow at a CAGR of 4.5% from 2024 to 2030. This is attributed to a combination of regulatory requirements, workplace safety concerns, and an increasing societal emphasi... Read More »
September 2024The China Alzheimer’s disease diagnostics market size was estimated at USD 287.76 million in 2023 and is expected to grow at a CAGR of 12.1% from 2024 to 2030. The increasing prevalence of Alzheimer’s disease (AD), growing use of biomarkers in disease diagnostics, growing ado... Read More »
September 2024The Latin America PoC infectious disease testing market size was estimated at USD 886.6 million in 2023 and is anticipated to grow at a CAGR of 2.7% from 2024 to 2030. This growth is driven by the high prevalence of infectious diseases, advancements in diagnostic technologies, supportive... Read More »
September 2024The Asia Pacific point of care TB and drug-resistant TB testing market size was estimated at USD 2.53 billion in 2023 and is anticipated to grow at a CAGR of 6.6% from 2024 to 2030. This growth is driven by the region's high TB burden, technological advancements in diagnostics, supportiv... Read More »
September 2024The Europe point of care TB and drug-resistant TB testing market size was estimated at USD 102.6 million in 2023 and is expected to grow at a CAGR of 5.7% from 2024 to 2030. The high prevalence of TB and DR-TB in Europe, coupled with increasing governmental and organizational initiatives... Read More »
September 2024The China lung cancer screening market size was estimated at USD 505.17 million in 2023 and is projected to grow at CAGR of 11.09% from 2024 to 2030. The growth of the market is driven by several key factors, including the high prevalence of lung cancer, advances in screening technology,... Read More »
September 2024